Primary tabs

Development of the Hemafuse Autologous Transfusion Device to Treat Ruptured Ectopic Pregnancies in Sub-Saharan Africa

Sisu Global Health (previously, DIIME and CentriCycle) is creating a new standard of care for autologous blood transfusion. The Hemafuse is handheld, electricity-independent, locally-affordable tool designed be a safer, faster replacement. The device is syringe-like to manually suction and filter the blood for transfusion in a sterile, closed environment; decreasing risk of clots and of infection and promises to decrease the mortality of women.

Grant ID
SLAB-POC-AID-27
Show on Hub
On
Show on Spoke
On
Lead Funding Organization
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
250000.00
Funding Currency
USD
Funding Amount (in USD)
250000.00
Funding Date Range
-
Funding Total (In US dollars)
250000.00
Co-Funded
False